Last reviewed · How we verify

i.v. sodium bicarbonate — Competitive Intelligence Brief

i.v. sodium bicarbonate (i.v. sodium bicarbonate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Buffer / alkalinizing agent. Area: Critical Care / Emergency Medicine.

phase 3 Buffer / alkalinizing agent Critical Care / Emergency Medicine Small molecule Live · refreshed every 30 min

Target snapshot

i.v. sodium bicarbonate (i.v. sodium bicarbonate) — G. d'Annunzio University. Intravenous sodium bicarbonate raises blood pH and alkalinity to counteract metabolic acidosis and improve systemic acid-base balance.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
i.v. sodium bicarbonate TARGET i.v. sodium bicarbonate G. d'Annunzio University phase 3 Buffer / alkalinizing agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Buffer / alkalinizing agent class)

  1. G. d'Annunzio University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). i.v. sodium bicarbonate — Competitive Intelligence Brief. https://druglandscape.com/ci/i-v-sodium-bicarbonate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: